EGFRvIII is a kind of “driving” cell for heterogeneity maintenance and tumor progression in GBM.
EGFRvIII external secretion has obvious supporting role in the entire tumor growth in vitro and in vivo.
Signal peptidase in the endoplasmic reticulum (ER) membrane may be a suitable therapeutic target for GBM intervention.